STOCK TITAN

Launch One Acquisition (LPAA) 10-K Filings

LPAA NASDAQ

Here are the 10-K annual reports from Launch One Acquisition Corp. (LPAA) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow LPAA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LPAA filings page.

Rhea-AI Summary

Launch One Acquisition Corp., a Cayman Islands-based SPAC focused on life sciences, reports that it raised $230,000,000 in its July 2024 IPO by selling 23,000,000 units at $10.00 each, plus $6,000,000 from 6,000,000 private placement warrants. As of December 31, 2025, $230,000,000 was held in a trust account, supporting an estimated redemption price of about $10.67 per public share, and funds available for a business combination were $245,449,353 before redemptions and fees.

The company must complete an initial business combination by July 15, 2026 or liquidate and return cash to public shareholders. A previously agreed transaction with Minovia Therapeutics was terminated by mutual agreement on January 30, 2026, and all related liabilities were released, so Launch One is now seeking an alternative target. The filing highlights typical SPAC risks, including potential conflicts of interest, the need to satisfy Nasdaq’s 36‑month combination requirement, creditor claims against trust funds, and limits on large redemptions.

The company notes broader geopolitical and macro risks, including conflicts involving Ukraine, Russia, the United States, Israel and Iran, which could disrupt capital markets or target operations and make closing a deal more difficult. Launch One also acknowledges cybersecurity risk as a pre‑revenue shell that relies heavily on third‑party systems but reports no incidents to date. As of March 26, 2026, it had 23,000,000 Class A and 5,750,000 Class B ordinary shares outstanding and continues to qualify as an emerging growth and smaller reporting company.